Core Viewpoint - The company, Meihao Medical, is a leading player in the cochlear implant market and is actively involved in the development of brain-machine interface (BMI) technologies, highlighting the potential for long-term applications in clinical settings [1] Group 1: Company Overview - Meihao Medical is recognized as a strategic partner and core supplier in the global cochlear implant industry, with nearly 15 years of deep collaboration with clients in the development and production of cochlear implant components [1] - The company emphasizes that cochlear implants are a successful example of current clinical applications and have a design lifespan that supports long-term or even lifetime use [1] Group 2: Industry Insights - The invasive brain-machine interface products share significant technological similarities with cochlear implants, particularly in areas such as material selection, biocompatibility requirements, production processes, and quality system control [1] - The company is engaged in in-depth process exploration and technical cooperation with innovative BMI clients, assisting them in transitioning from laboratory research to efficient commercial production [1] - Currently, the revenue generated from the company's brain-machine interface business is relatively small, indicating potential growth opportunities in this emerging sector [1]
美好医疗：目前公司脑机接口业务产生的收入规模较小